Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.82 CAD | -5.12% | -7.66% | -10.58% |
Apr. 16 | VBI Vaccines Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 15 | North American Morning Briefing : Stock Futures -2- | DJ |
Sales 2024 * | 14.48M 19.82M | Sales 2025 * | 34.12M 46.69M | Capitalization | 16.92M 23.16M |
---|---|---|---|---|---|
Net income 2024 * | -42M -57.47M | Net income 2025 * | -25M -34.21M | EV / Sales 2024 * | 1.17 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.5 x |
P/E ratio 2024 * |
-0.42
x | P/E ratio 2025 * |
-1.16
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.01% |
1 day | -5.12% |
Managers | Title | Age | Since |
---|---|---|---|
Jeff Baxter
CEO | Chief Executive Officer | 62 | 16-04-30 |
Nell Beattie
DFI | Director of Finance/CFO | 36 | 15-07-08 |
David Anderson
CTO | Chief Tech/Sci/R&D Officer | 54 | 16-05-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Vaughn Himes
BRD | Director/Board Member | 63 | 23-04-23 |
Steven Gillis
CHM | Chairman | 71 | 04-12-31 |
Jeff Baxter
CEO | Chief Executive Officer | 62 | 16-04-30 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- VBIV Stock
- VBV Stock